Clinical Trial Update: Dexmedetomidine Sublingual Film for the Management of Agitation in Delirium: Safety and Preliminary Efficacy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a dexmedetomidine sublingual film for agitation in delirium was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delirium

Drugs mentioned

• Dexmedetomidine Sublingual Film (dexmedetomidine)

Snippet

Sponsor: Jeff C. Huffman, MD | Conditions: Delirium | Phase 2 | Status: WITHDRAWN